These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28925169)

  • 41. [Methodological quality evaluation of randomized controlled trials for traditional Chinese medicines for treatment of sub-health].
    Zhao J; Liao X; Zhao H; Li ZG; Wang NY; Wang LM
    Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4041-4050. PubMed ID: 28929694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan).
    Grosset DG; Tatsch K; Oertel WH; Tolosa E; Bajaj N; Kupsch A; O'Brien JT; Seibyl J; Walker Z; Sherwin P; Chen C; Grachev ID
    J Nucl Med; 2014 Aug; 55(8):1281-7. PubMed ID: 24947061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Real world study of affect on liver function of overdose of salvianolate extract injection].
    Chang YP; Huo J; Xie YM; Zhang H; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3092-8. PubMed ID: 24471334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Systematic review and Meta-analysis of Shenqi Fuzheng injection combined with first-line chemotherapy for non-small cell lung cancer].
    Hao TT; Xie YM; Liao X; Wang J
    Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(20):4094-107. PubMed ID: 27062833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials.
    Luo H; Li Q; Flower A; Lewith G; Liu J
    J Ethnopharmacol; 2012 Apr; 140(3):555-67. PubMed ID: 22343092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of salvianolate injection combined with usual drugs in treatment of coronary heart disease in real world].
    Chang YP; Zhang H; Xie YM; Zeng XB; Hu J; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3186-9. PubMed ID: 24471349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation on safety of puerarin injection in clinical use].
    Xie XS; Dong YZ; Mu DP; Pan XL; Zhang FY
    Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(19):3956-3961. PubMed ID: 30453723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-marketing safety surveillance and reevaluation of Motherwort injection: A clinical study of 10 094 cases.
    Cao Shan DOSOGC; Zhang W; Zhao Z; Heng M; Bu H; Wang H; Liu X; Wang Z; Cai Y; Ma Y; Cui Shihong DOO; Deng J; Yang Y; Ding G; Ding Y; Dong L; Duan Z; Fan L; Fan Y; Fu F; He J; Ji S; Jin L; Li H; Li H; Liao T; Lu W; Luo X; Lü Z; Ma F; Ma D; Shi T; Sun J; Teng H; Wang J; Wang R; Wang Y; Wang Z; Xi J; Xu M; Xu Z; Yan Q; Zhang G; Yang C; Yin J; Yu J; Yuan W; Zhang M; Zhao R; Zhong Y; Zhou J
    J Tradit Chin Med; 2018 Aug; 38(4):625-635. PubMed ID: 32186089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and Economic Evaluation of Salvianolate Injection for Coronary Heart Disease: A Retrospective Study Based on National Health Insurance Data in China.
    Yang L; Chen X; Oi Lam Ung C; Zhu H; Hu H; Han S
    Front Pharmacol; 2020; 11():887. PubMed ID: 32625090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of an injection with a mixture of extracts from Herba Artemisiae annuae, Fructus Gardeniae and Flos Lonicerae.
    Xu HM; Wang Y; Liu NF
    Pharm World Sci; 2009 Aug; 31(4):458-463. PubMed ID: 19381859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease.
    Dong P; Hu H; Guan X; Ung COL; Shi L; Han S; Yu S
    Chin Med; 2018; 13():28. PubMed ID: 29946348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse reactions of piperacillin: A literature review of case reports.
    Zhang H; Yang L
    Open Med (Wars); 2024; 19(1):20240931. PubMed ID: 38623456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [32 546 intensive hospital monitoring cases of Shuxuetong injection].
    Jiang JJ; Xie YM; Zhang Y; Yang ZX; Yi DH
    Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3852-3858. PubMed ID: 28929666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intensive hospital monitoring of Shuxuening injection in 30 209 cases].
    Jiang JJ; Xie YM; Zhang Y; Li MQ; Zhao YB; Wen ZH; Li XL; Yi DH; Zhang YK
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2883-2888. PubMed ID: 29139252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normative Application of Xiyanping Injection: A Systematic Review of Adverse Case Reports.
    Chen S; Kwong JSW; Zheng R; Wang Y; Shang H
    Evid Based Complement Alternat Med; 2018; 2018():4013912. PubMed ID: 30581483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Safety evaluation of Sophora tonkinensis and risk control].
    Chen D; Gao XM; Zhang L; Fu L; Yao JK; Wang LL; Sun XB; Wang JX
    Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(21):4086-4092. PubMed ID: 29271144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of skin hyperpigmentation and drug use: a systematic review.
    Krause W
    G Ital Dermatol Venereol; 2016 Dec; 151(6):694-699. PubMed ID: 27248149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse cutaneous reactions to guggulipid.
    Gelfand JM; Crawford GH; Brod BA; Szazpary PO
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):533-4. PubMed ID: 15761442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.